<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Degradable polymer prodrugs with adjustable activity from drug-initiated radical ring-opening copolymerization †</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2018-09-13">13 September 2018</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Elise</forename><surname>Gu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Faculté de Pharmacie</orgName>
								<orgName type="laboratory">UMR 8612</orgName>
								<orgName type="institution" key="instit1">Institut Galien Paris-Sud</orgName>
								<orgName type="institution" key="instit2">CNRS</orgName>
								<orgName type="institution" key="instit3">Univ Paris-Sud</orgName>
								<address>
									<addrLine>5 rue Jean-Baptiste Clément</addrLine>
									<postCode>92290</postCode>
									<settlement>Châtenay-Malabry</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johanna</forename><surname>Tran</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Faculté de Pharmacie</orgName>
								<orgName type="laboratory">UMR 8612</orgName>
								<orgName type="institution" key="instit1">Institut Galien Paris-Sud</orgName>
								<orgName type="institution" key="instit2">CNRS</orgName>
								<orgName type="institution" key="instit3">Univ Paris-Sud</orgName>
								<address>
									<addrLine>5 rue Jean-Baptiste Clément</addrLine>
									<postCode>92290</postCode>
									<settlement>Châtenay-Malabry</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Quentin</forename><surname>Deguettes</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Faculté de Pharmacie</orgName>
								<orgName type="laboratory">UMR 8612</orgName>
								<orgName type="institution" key="instit1">Institut Galien Paris-Sud</orgName>
								<orgName type="institution" key="instit2">CNRS</orgName>
								<orgName type="institution" key="instit3">Univ Paris-Sud</orgName>
								<address>
									<addrLine>5 rue Jean-Baptiste Clément</addrLine>
									<postCode>92290</postCode>
									<settlement>Châtenay-Malabry</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Julien</forename><surname>Nicolas</surname></persName>
							<email>julien.nicolas@u-psud.fr</email>
							<affiliation key="aff0">
								<orgName type="department">Faculté de Pharmacie</orgName>
								<orgName type="laboratory">UMR 8612</orgName>
								<orgName type="institution" key="instit1">Institut Galien Paris-Sud</orgName>
								<orgName type="institution" key="instit2">CNRS</orgName>
								<orgName type="institution" key="instit3">Univ Paris-Sud</orgName>
								<address>
									<addrLine>5 rue Jean-Baptiste Clément</addrLine>
									<postCode>92290</postCode>
									<settlement>Châtenay-Malabry</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Degradable polymer prodrugs with adjustable activity from drug-initiated radical ring-opening copolymerization †</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2018-09-13">13 September 2018</date>
						</imprint>
					</monogr>
					<idno type="MD5">4632AF93DDAC7666C4171098B33A1B99</idno>
					<idno type="DOI">10.1039/c8sc02256a</idno>
					<note type="submission">Received 22nd May 2018 Accepted 28th August 2018</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Degradable polymer prodrugs based on gemcitabine (Gem) as an anticancer drug were synthesized by 'drug-initiated' nitroxide-mediated radical ring-opening copolymerization (NMrROP) of methacrylic esters and 2-methylene-4-phenyl-1,3-dioxolane (MPDL).</s><s>Different structural parameters were varied to determine the best biological performances: the nature of the monomer [i.e., oligo(ethylene glycol) methacrylate (OEGMA) or methyl methacrylate (MMA)], the nature of the Gem-polymer linker (i.e., amide or amide and diglycolate) and the MPDL content in the copolymer.</s><s>Depending on the nature of the methacrylate monomer, two small libraries of water-soluble copolymer prodrugs and nanoparticles were obtained (M n $10 000 g mol À1 , Đ ¼ 1.1-1.5),</s><s>which exhibited tunable hydrolytic degradation under accelerated conditions governed by the MPDL content.</s><s>Drug-release profiles in human serum and in vitro anticancer activity on different cell lines enabled preliminary structure-activity relationships to be established.</s><s>The cytotoxicity was independently governed by: (i) the MPDL contentthe lower the MPDL content, the greater the cytotoxicity; (ii) the nature of the linkerthe presence of a labile diglycolate linker enabled a greater Gem release compared to a simple amide bond and (iii) the hydrophilicity of the methacrylate monomer-OEGMA enabled a greater anticancer activity to be obtained compared to MMA-based polymer prodrugs.</s><s>Remarkably, the optimal structural parameters enabled reaching the cytotoxic activity of the parent (free) drug.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>In the eld of nanomedicine, use of drug-loaded polymer nanocarriers is considered as a promising strategy to improve the efficacy of drugs such as chemotherapeutics. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref></s><s>Traditionally, drugs are physically encapsulated during the nanocarrier formulation and thus simply entrapped into the polymer matrix.</s><s>These drug delivery systems lead to protection of the drug from rapid metabolization, to longer circulation time, to lower toxicity toward healthy cells/tissues and open the door to active targeting by their surface-functionalization using biologically active ligands.</s><s>Despite major advances and encouraging results, important limitations remain that may explain the small number of marketed nanomedicines and recent clinical trial disappointments: (i) the "burst-release", that is, the quick and uncontrolled release of a signicant fraction of the drug post-injection; (ii) the poor drug-loadings, usually only a few percent and (iii) the crystallization of some drugs into the polymer matrix.</s><s>These three different events can lead to prohibitive toxicity and/or colloidal instability of the nanocarriers.</s></p><p><s>The prodrug strategy, which consists in coupling the drug to the nanocarrier, can be used to circumvent, or at least alleviate, the above-mentioned issues. <ref type="bibr" target="#b2">3</ref></s><s>Among the different synthetic pathways to produce polymer prodrug nanocarriers, the most used are certainly the "graing to" and "graing from" approaches that consist in functionalization of the preformed polymer or monomer, respectively.</s><s>The emerging "graing from" strategy (also called "drug-initiated"), that relies on the controlled growth of a short polymer chain from a drug, used as an initiator, has appealing benets: <ref type="bibr" target="#b3">4</ref> (i) the synthesis and purication are simple because only a few synthetic steps are necessary; (ii) the resulting materials have a simple, well-dened structure (one drug attached at the extremity of each polymer chain); (iii) high drug loadings can be easily reached by targeting short polymer chains; (iv) this approach can be applied to different pathologies simply by changing the nature of the drug and (v) the properties of the resulting polymer prodrug can be nely tuned by changing the nature of the growing polymer.</s></p><p><s>The robustness of the drug-initiated method has been illustrated by its application to the synthesis of a variety of different polymer prodrugs constructed by either ring-opening polymerization (ROP) <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref> or reversible-deactivation radical polymerization (RDRP), <ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref> including nitroxide-mediated radical polymerization (NMP) <ref type="bibr" target="#b18">19</ref> or reversible additionfragmentation chain transfer (RAFT) polymerization. <ref type="bibr" target="#b19">20</ref></s><s>hereas ROP generated degradable polyester prodrug nanocarriers, they exhibited poor colloidal stability and required post-stabilization by means of macromolecular surfactants, which is a major drawback.</s><s>Also, no in vivo anticancer activity has been reported from these systems.</s><s>On the other hand, RDRP-constructed polymer prodrugs gave promising anticancer efficacy in vivo, relied on simpler polymerization methods (e.g., no stringent conditions, commercially available controlling agents) and offered much more versatility regarding the nature of the polymer used.</s><s>However, they are not degradable because of the carbon-carbon backbone of the vinyl polymer chains.</s><s>This represents an important drawback because nondegradable materials may accumulate in the body, leading to prohibitive toxicity in case chronic/repeated administration is envisioned.</s><s>A global strategy combining both the advantages of ROP and RDRP for the design of efficient polymer prodrugs by the "drug-initiated" approach is thus highly desirable.</s></p><p><s>Conferring degradability to vinyl materials is currently the focus of intensive work. <ref type="bibr" target="#b20">21</ref></s><s>This research topic is crucial given the numerous systems based on vinyl polymers devoted to biomedical applications regularly being reported in the literature.</s><s>Among the different synthetic strategies, radical ringopening polymerization (rROP) appears to be the method of choice for incorporating labile groups into the polymer backbone and enabling signicant degradation. <ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23</ref></s><s>Thanks to its radical ring-opening mechanism, rROP possesses both the versatility and simplicity of radical polymerization, together with the ability to introduce functional groups into the polymer backbone.</s><s>Among the different classes of monomers that have been polymerized by rROP, cyclic ketene acetals (CKAs) are the most-studied family.</s><s>]<ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref> Other cyclic monomers deriving from cyclic allylic suldes <ref type="bibr" target="#b45">[46]</ref><ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref> have also been used to incorporate cleavable ester, thioester, and disulde functionalities into the polymer backbone through RAFT copolymerization with traditional vinyl monomers. <ref type="bibr" target="#b40">41</ref></s><s>Despite several applications of rROP-designed materials for biomedical applications, <ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref> their use in the eld of prodrug nanocarriers has only been reported from preformed functional copolymers via the "graing to" approach. <ref type="bibr" target="#b51">52,</ref><ref type="bibr" target="#b52">53</ref></s><s>erein, we report for the rst time on a general approach that combines the best of two worlds, that is, the drug-initiated synthesis of degradable polymer prodrugs by rROP.</s><s>We demonstrated that well-dened, degradable vinyl copolymers can be synthesized from an anticancer drug-bearing RDRP initiator by rROP, leading to nanocarriers, either water-soluble conjugates or nanoparticles (Fig. <ref type="figure" target="#fig_1">1</ref>), with adjustable anticancer activity depending on the nature of both the drugpolymer linkage and the copolymer.</s><s>Not only this new class of polymer prodrugs overcame a signicant obstacle in the eld, but it also disclosed important insights into the relevant parameters that govern the drug release kinetics and eventually the anticancer activity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Experimental section</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials</head><p><s>Gemcitabine (&gt;98%) was purchased from Carbosynth Limited (UK).</s><s>Oligo(ethylene glycol) methyl ether methacrylate (MeOEGMA, M n ¼ 300 g mol À1 ), styrene (S, 99%), methyl methacrylate (MMA, 99%) and toluene (anhydrous, 99.8%) were purchased from Sigma-Aldrich (France) and used as received (except for MMA which was distilled under reduced pressure).</s><s>2-Methylene-4-phenyl-1,3-dioxolane (MPDL), <ref type="bibr" target="#b53">54</ref>   uoride (TBAF) was purchased from Alfa Aesar (a Johnson Matthey Co., France).</s><s>Peruoro-15-Crown-5-Ether (PFCE) was obtained from FluoroChem (UK).</s><s>All other reactants were purchased from Sigma-Aldrich at the highest available purity and used as received.</s><s>Deuterated chloroform (CDCl 3 ) and dimethyl sulfoxide (DMSO-d 6 ) were obtained from Eurisotop.</s><s>All other solvents were purchased from Carlo-Erba.</s><s>Dulbecco's modied eagle's medium (DMEM) and fetal bovine serum (FBS) were purchased from Dulbecco (Invitrogen, France).</s><s>Penicillin and streptomycin were obtained from Lonza (Verviers, Belgium).</s><s>2-Methyl-2-[N-tert-butyl-N-(1diethoxyphosphoryl-2,2-dimethylpropyl) aminoxy]propionic acid alkoxyamine (BlocBuilder MA, 99%) and N-tert-butyl-N-(1diethylphosphono-2,2-dimethylpropyl) nitroxide (SG1, 85%) were kindly supplied by Arkema.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analytical method</head><p><s>Nuclear magnetic resonance (NMR) spectroscopy.</s><s>NMR spectroscopy was performed in 5 mm diameter tubes in CDCl 3 at 25 C. <ref type="bibr" target="#b0">1</ref> H NMR or <ref type="bibr" target="#b12">13</ref> C NMR spectroscopy was performed on a Bruker Avance 300 spectrometer at 300 MHz ( 1 H) or 75 MHz ( 13 C).</s><s>The chemical shi scale was calibrated based on the internal solvent signals. <ref type="bibr" target="#b18">19</ref></s><s>F NMR spectra were recorded on a Bruker Avance 400 at 376.5 MHz.</s><s>The chemical shi scale was calibrated relative to an internal standard (PFCE, d ¼ À88 ppm).</s></p><p><s>Mass spectrometry (MS).</s><s>Mass spectra were recorded with a Bruker Esquire-LC instrument.</s><s>High-resolution (HR) mass spectra (electron spin ionization, ESI) were recorded on an ESI/TOF (LCT, Waters) LC-spectrometer.</s><s>Elemental analyses were performed by the Service de microanalyse, Centre d'Etudes Pharmaceutiques, Châtenay-Malabry, France, with a Perki-nElmer 2400 analyzer.</s></p><p><s>Size exclusion chromatography (SEC).</s><s>SEC was performed at 30 C with two columns from Polymer Laboratories (PL-gel MIXED-D; 300 Â 7.5 mm; bead diameter, 5 mm; linear part, 400-400 000 g mol À1 ) and a differential refractive index detector (Spectrasystem RI-150 from Thermo Electron Corp.), using chloroform (CHCl 3 ) as the eluent at a ow rate of 1 mL min À1 .</s><s>Toluene was used as a ow-rate marker.</s><s>The conventional calibration curve was based on poly(methyl methacrylate) (PMMA) standards (peak molar masses, M p ¼ 625-625 500 g mol À1 ) from Polymer Laboratories.</s><s>This technique allowed M n (number-average molar mass), M w (weight-average molar mass), and M w /M n (dispersity, Đ) to be determined.</s></p><p><s>Dynamic light scattering (DLS) and zeta potential.</s><s>Nanoparticle diameters (D z ) and zeta potentials (z) were measured by dynamic light scattering (DLS) with a Nano ZS from Malvern (173 scattering angle) at a temperature of 25 C.</s><s>The surface charge of the nanoparticles was determined by z-potential (mV) measurement at 25 C aer dilution with 1 mM NaCl, using the Smoluchowski equation.</s></p><p><s>Cryogenic transmission electron microscopy (cryo-TEM).</s><s>The morphology of the nanoassemblies was observed by cryo-TEM.</s><s>Briey, 5 mL of the nanoparticle suspension (0.5 mg mL À1 ) was deposited on a Lacey Formvar/carbon 300 mesh copper microscopy grid (Ted Pella).</s><s>Most of the drop was removed with a blotting lter paper and the residual thin lm remaining within the holes was vitried by plunging into liquid ethane.</s><s>Samples were then observed using a JEOL 2100HC microscope.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthetic procedures</head><p><s>Synthesis of Gem-digly-AMA-SG1.</s><s>TBDMS-Gem (3.0 g, 6.1 mmol), AMA-digly (2.5 g, 4.7 mmol) and benzotriazol-1-yloxytripyrrolidinophosphonium hexauorophosphate (PyBOP, 3.2 g, 6.1 mmol) were dissolved in 30 mL of dry DMF.</s><s>N,N-Diisopropylethylamine (DIPEA, 2.2 mL, 12.4 mmol) was added dropwise.</s><s>Aer stirring at 30 C for 24 h in a nitrogen atmosphere, the mixture was poured into 200 mL of EtOAc.</s><s>The organic phase was washed with 1 M HCl, sat.</s><s>NaHCO 3 aqueous solution, and brine before being dried over MgSO 4 .</s><s>The residue was concentrated under reduced pressure and puried by ash chromatography (SiO 2 , gradient elution from EtOAc/petroleum ether ¼ 1/1, v/v to EtOAc) to give 2.01 g of Gem-digly-AMA-SG1 as a white/slightly orange solid (Fig. <ref type="figure" target="#fig_1">S1 †</ref>).</s><s>Yield ¼ 42%. <ref type="bibr" target="#b0">1</ref>  Synthesis of Gem-poly[(oligo(ethylene glycol) methyl ether methacrylate)-co-(2-methylene-4-phenyl-1,3-dioxolane)] (Gem-P(OEGMA-co-MPDL)).</s><s>A typical solution copolymerization procedure (f MPDL,0 ¼ 0.2, expt 1) is described as follows.</s><s>In a 7 mL vial tted with a rubber septum and a magnetic stirring bar, a mixture of OEGMA (1.3214 g, 4.40 mmol, M n ¼ 300 g mol À1 ), MPDL (0.1786 g, 1.10 mmol), Gem-AMA-SG1 (28.0 mg, 4.58 Â 10 À2 mmol), SG1 (1.5 mg, 4.39 Â 10 À3 mmol) and anhydrous toluene (1.5 g, 1.73 mL) was degassed under stirring by argon bubbling for 15 min at room temperature.</s><s>The mixture was then immersed in a preheated oil bath at 90 C, corresponding to the time zero of the reaction (according to the small volume of solution and its quasi-instantaneous heating).</s><s>Samples were periodically taken to monitor the OEGMA conversion by <ref type="bibr" target="#b0">1</ref> H NMR spectroscopy and the macromolecular characteristics (M n and Đ) by SEC.</s><s>The copolymer was then precipitated twice in a mixture of cold cyclohexane/petroleum ether (1/1, v/v) and dried under high vacuum until constant weight.</s><s>The same procedure was followed by adapting the amount of the reactants for f MPDL,0 ¼ 0.4 (expt 2) [OEGMA (1.1028 g, 3.68 mmol), MPDL (0.3972 g, 2.45 mmol), Gem-AMA-SG1 (23.0 mg, 3.76 Â 10 À2 mmol) and SG1 (1.3 mg, 3.80 Â 10 À3 mmol)] and f MPDL,0 ¼ 0.7 (expt 3) [OEGMA (0.6633 g, 2.21 mmol), MPDL (0.8367 g, 5.17 mmol), Gem-AMA-SG1 (13.8 mg, 2.31 Â 10 À2 mmol) and SG1 (0.8 mg, 2.34 Â 10 À3 mmol)].</s></p><p><s>Synthesis of Gem-digly-poly[(oligo(ethylene glycol) methyl ether methacrylate)-co-(2-methylene-4-phenyl-1,3-dioxolane)] (Gem-digly-P(OEGMA-co-MPDL)).</s><s>A typical solution copolymerization procedure (f MPDL,0 ¼ 0.2, expt 1d) is as follows.</s><s>In a 7 mL vial, tted with a rubber septum and a magnetic stirring bar, a mixture of OEGMA (1.3214 g, 4.40 mmol), MPDL (0.1786 g, 1.10 mmol), Gem-digly-AMA-SG1 (45.0 mg, 4.50 Â 10 À2 mmol), SG1 (1.5 mg, 4.39 Â 10 À3 mmol) and anhydrous toluene (1.5 g, 1.73 mL) was degassed under stirring by argon bubbling for 15 min at room temperature.</s><s>The mixture was then immersed in a preheated oil bath at 90 C. Samples were periodically taken to monitor the OEGMA conversion by <ref type="bibr" target="#b0">1</ref> H NMR spectroscopy and the macromolecular characteristics (M n and Đ) by SEC.</s><s>The copolymer was then precipitated twice in a mixture of cold cyclohexane/petroleum ether (1/1, v/v) and dried under high vacuum until constant weight.</s><s>The same procedure was followed by adapting the amount of the reactants for f MPDL,0 ¼ 0.4 (expt 2d) [OEGMA (1.1028 g, 3.68 mmol), MPDL (0.3972 g, 2.45 mmol), Gem-digly-AMA-SG1 (38.0 mg, 3.80 Â 10 À2 mmol) and SG1 (1.3 mg, 3.80 Â 10 À3 mmol)] and f MPDL,0 ¼ 0.7 (expt 3d) [OEGMA (0.6633 g, 2.21 mmol), MPDL (0.8367 g, 5.17 mmol), Gem-digly-AMA-SG1 (23.0 mg, 2.30 Â 10 À2 mmol) and SG1 (0.8 mg, 2.34 Â 10 À3 mmol)].</s></p><p><s>Synthesis of Gem-poly[(methyl methacrylate)-co-(2-methylene-4-phenyl-1,3-dioxolane)] (Gem-P(MMA-co-MPDL)).</s><s>A typical solution copolymerization procedure (f MPDL,0 ¼ 0.2, expt 4) is as follows.</s><s>In a 7 mL vial, tted with a rubber septum and a magnetic stirring bar, a mixture of MMA (1.0673 g, 10.67 mmol), MPDL (0.4327 g, 2.67 mmol), Gem-AMA-SG1 (22.0 mg, 3.59 Â 10 À2 mmol), SG1 (1.3 mg, 3.80 Â 10 À3 mmol) and anhydrous toluene (1.5 g, 1.73 mL) was degassed under stirring by argon bubbling for 15 min at room temperature.</s><s>The mixture was then immersed in a preheated oil bath at 90 C. Samples were periodically taken to monitor the MMA conversion by <ref type="bibr" target="#b0">1</ref> H NMR spectroscopy and the macromolecular characteristics (M n and Đ) by SEC.</s><s>The copolymer was then precipitated twice in cold MeOH and dried under high vacuum until constant weight.</s><s>The same procedure was followed by adapting the amount of the reactants for f MPDL,0 ¼ 0.4 (expt 5) [MMA (0.7215 g, 7.22 mmol), MPDL (0.7785 g, 4.81 mmol), Gem-AMA-SG1 (15.0 mg, 2.45 Â 10 À2 mmol) and SG1 (0.9 mg, 2.49 Â 10 À3 mmol)] and f MPDL,0 ¼ 0.7 (expt 6) [MMA (0.3135 g, 3.14 mmol), MPDL (1.1865 g, 7.32 mmol), Gem-AMA-SG1 (6.5 mg, 1.06 Â 10 À2 mmol) and SG1 (0.4 mg, 1.02 Â 10 À3 mmol)].</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthesis of Gem-digly-poly[(methyl methacrylate)-co-(2methylene-4-phenyl-1,3-dioxolane)] (Gem-digly-P(MMA-co-MPDL)).</head><p><s>A typical solution copolymerization procedure (f MPDL,0 ¼ 0.2, expt 4d) is as follows.</s><s>In a 7 mL vial, tted with a rubber septum and a magnetic stirring bar, a mixture of MMA (1.0673 g, 10.67 mmol), MPDL (0.4327 g, 2.67 mmol), Gem-digly-AMA-SG1 (36.0 mg, 3.60 Â 10 À2 mmol), SG1 (1.3 mg, 3.80 Â 10 À3 mmol) and anhydrous toluene (1.5 g, 1.73 mL) was degassed under stirring by argon bubbling for 15 min at room temperature.</s><s>The mixture was then immersed in a preheated oil bath at 90 C. Samples were periodically taken to monitor the MMA conversion by 1 H NMR spectroscopy and the macromolecular characteristics (M n and Đ) by SEC.</s><s>The copolymer was then precipitated twice in cold MeOH and dried under high vacuum until constant weight.</s><s>The same procedure was followed by adapting the amount of the reactants for f MPDL,0 ¼ 0.4 (expt 5d) [MMA (0.7215 g, 7.22 mmol), MPDL (0.7785 g, 4.81 mmol), Gem-digly-AMA-SG1 (25.0 mg, 2.5 Â 10 À2 mmol) and SG1 (0.9 mg, 2.49 Â 10 À3 mmol)] and f MPDL,0 ¼ 0.7 (expt 6d) [MMA (0.3135 g, 3.14 mmol), MPDL (1.1865 g, 7.32 mmol), Gem-digly-AMA-SG1 (10.5 mg, 1.05 Â 10 À2 mmol) and SG1 (0.4 mg, 1.02 Â 10 À3 mmol)].</s></p><p><s>Synthesis of low molar mass Gem-poly[(oligo(ethylene glycol) methyl ether methacrylate)-co-(2-methylene-4-phenyl-1,3-dioxolane)] (Gem-P(OEGMA-co-MPDL)).</s><s>Copolymers with a targeted M n of $10 000 g mol À1 were prepared by following a similar procedure to that of expt 1 but with a polymerization time of 8 h.</s><s>Experimental conditions were as follows: P1 (f MPDL,0 ¼ 0.2) [OEGMA (1.7618 g, 5.87 mmol), MPDL (0.2382 g, 1.47 mmol), Gem-AMA-SG1 (200.0 mg, 3.27 Â 10 À1 mmol), SG1 (12 mg, 3.51 Â 10 À2 mmol) and anhydrous toluene (2.0 g, 2.31 mL)], P2 (f MPDL,0 ¼ 0.4) [OEGMA (1.4704 g, 4.90 mmol), MPDL (0.5296 g, 3.27 mmol), Gem-AMA-SG1 (205.0 mg, 3.35 Â 10 À1 mmol), SG1 (12 mg, 3.51 Â 10 À2 mmol) and anhydrous toluene (2.0 g, 2.31 mL)] and P3 (f MPDL,0 ¼ 0.7) [OEGMA (0.8862 g, 2.95 mmol), MPDL (1.1138 g, 6.88 mmol), Gem-AMA-SG1 (65.0 mg, 1.06 Â 10 À1 mmol), SG1 (3.6 mg, 1.05 Â 10 À2 mmol) and anhydrous toluene (2.0 g, 2.31 mL)].</s><s>The nal composition of the prodrug was determined by comparing the methoxy protons of OEG from OEGMA (at 3.4 ppm) to the aromatic protons of MPDL (at 7.2 ppm).</s><s>The presence of Gem was quantitatively conrmed by <ref type="bibr" target="#b18">19</ref> F NMR by comparing the integration of the uorine atoms of the internal standard PFCE (d ¼ À88 ppm) and of Gem (d ¼ À117 ppm).</s><s>Copolymers with lower targeted M n were prepared (Table <ref type="table" target="#tab_1">S1</ref> †) by following a similar procedure to that of P3: P3 0 (targeted M n ¼ 9000 g mol À1 , f MPDL,0 ¼ 0.7) [OEGMA (0.8955 g, 2.99 mmol), MPDL (1.113 g, 6.87 mmol), Gem-AMA-SG1 (65.9 mg, 0.11 mmol), SG1 (4.1 mg, 1.20 Â 10 À2 mmol) and anhydrous toluene (2.0 g, 2.31 mL)] and P3 00 (targeted M n ¼ 3500 g mol À1 , f MPDL,0 ¼ 0.7) [OEGMA (0.9328 g, 3.11 mmol), MPDL (1.205 g, 7.44 mmol), Gem-AMA-SG1 (187.8 mg, 0.31 mmol), SG1 (9.7 mg, 2.84 Â 10 À2 mmol) and anhydrous toluene (2.0 g, 2.31 mL)].</s></p><p><s>Synthesis of low molar mass Gem-digly-poly[(oligo(ethylene glycol) methyl ether methacrylate)-co-(2-methylene-4-phenyl-1,3-dioxolane)] (Gem-digly-P(OEGMA-co-MPDL)).</s><s>Copolymers with a targeted M n of $10 000 g mol À1 were prepared by following a similar procedure to that of expt 1 but with a polymerization time of 8 h.</s><s>Experimental conditions were as follows: P1d (f MPDL,0 ¼ 0.2) [OEGMA (0.8805 g, 2.93 mmol), MPDL (0.1195 g, 0.74 mmol), Gem-digly-AMA-SG1 (266.6 mg, 2.66 Â 10 À1 mmol), SG1 (9 mg, 2.63 Â 10 À2 mmol) and toluene (1.0 g, 1.15 mL)], for P2d (f MPDL,0 ¼ 0.4) [OEGMA (0.7375 g, 2.46 mmol), MPDL (0.2660 g, 1.64 mmol), Gem-digly-AMA-SG1 (93.3 mg, 9.32 Â 10 À2 mmol), SG1 (3.2 mg, 9.36 Â 10 À3 mmol) and toluene (1.0 g, 1.15 mL)] and for P3d (f MPDL,0 ¼ 0.7) [OEGMA (0.4420 g, 1.47 mmol), MPDL (0.5580 g, 3.44 mmol), Gem-digly-AMA-SG1 (53.3 mg, 5.33 Â 10 À2 mmol), SG1 (1.7 mg, 4.89 Â 10 À3 mmol) and toluene (1.0 g, 1.15 mL)].</s><s>The nal composition of the prodrug was determined by comparing the methoxy protons of OEG from OEGMA (at 3.4 ppm) with the aromatic protons of MPDL (at 7.2 ppm).</s><s>The presence of Gem was quantitatively conrmed by <ref type="bibr" target="#b18">19</ref> F NMR by comparing the integration of the uorine atoms of the internal standard PFCE (d ¼ À88 ppm) and of Gem (d ¼ À117 ppm).</s></p><p><s>Synthesis of low molar mass Gem-poly[(oligo(ethylene glycol) methyl ether methacrylate)-co-styrene] (Gem-P(OEGMAco-S)).</s><s>Polymer prodrugs without MPDL with a targeted M n of $10 000 g mol À1 were prepared by following a similar procedure to that of expt 1 but with a polymerization time of 8 h.</s><s>Experimental conditions were as follows: OEGMA (1.4436 g, 4.81 mmol), S (0.0563 g, 5.41 Â 10 À1 mmol), Gem-AMA-SG1 (7.0 mg, 1.14 Â 10 À1 mmol), and anhydrous toluene (1.5 g, 1.73 mL).</s><s>SEC:</s></p><formula xml:id="formula_0">M n ¼ 10 300 g mol À1 , M w /M n ¼ 1.29.</formula><p><s>Synthesis of low molar mass poly[(oligo(ethylene glycol) methyl ether methacrylate)-co-(2-methylene-4-phenyl-1,3dioxolane)] (P(OEGMA-co-MPDL)).</s><s>Copolymers without Gem P7 with a targeted M n of $10 000 g mol À1 and f MPDL,0 ¼ 0.4 were prepared by following a similar procedure to that of expt 1 but with a polymerization time of 8 h.</s><s>Experimental conditions were as follows: OEGMA (1.1028 g, 3.68 mmol), MPDL (0.3972 g, 2.45 mmol), BlocBuilder MA (15.0 mg, 3.94 Â 10 À2 mmol), and anhydrous toluene (1.5 g, 1.73 mL).</s><s>The nal composition of the copolymer was determined by comparing the terminal methoxy protons of pendant OEG for OEGMA (at 3.4 ppm) with the aromatic protons of MPDL (at 7.2 ppm).</s><s>SEC:</s></p><formula xml:id="formula_1">M n ¼ 12 100 g mol À1 , M w /M n ¼ 1.30. 1 H NMR: F MPDL ¼ 0.13.</formula><p><s>Synthesis of low molar mass Gem-poly[(methyl methacrylate)-co-(2-methylene-4-phenyl-1,3-dioxolane)] (Gem-P(MMA-co-MPDL)). Copolymers with a targeted M n of $10 000 g mol À1 were prepared by following a similar procedure to that of expt 4 but with a polymerization time of 5 h.</s><s>Experimental conditions were as follows: P4 (f MPDL,0 ¼ 0.2) [MMA (1.0673 g, 10.67 mmol), MPDL (0.4327 g, 2.67 mmol), Gem-AMA-SG1 (340.0 mg, 5.56 Â 10 À1 mmol), SG1 (18.1 mg, 5.29 Â 10 À2 mmol) and anhydrous toluene (1.5 g, 1.73 mL)], for P5 (f MPDL,0 ¼ 0.4) [MMA (0.7215 g, 7.22 mmol), MPDL (0.7785 g, 4.81 mmol), Gem-AMA-SG1 (230 mg, 3.76 Â 10 À1 mmol), SG1 (12.3 mg, 3.60 Â 10 À2 mmol) and anhydrous toluene (1.5 g, 1.73 mL)] and for P6 (f MPDL,0 ¼ 0.7) [MMA (0.3135 g, 3.14 mmol), MPDL (1.1865 g, 7.32 mmol), Gem-AMA-SG1 (30.0 mg, 4.90 Â 10 À2 mmol), SG1 (1.6 mg, 4.69 Â 10 À3 mmol) and anhydrous toluene (1.5 g, 1.73 mL)].</s><s>The nal composition of the prodrug was determined by comparing the methyl protons in the a-position to the ester group of MMA (at 3.7 ppm) with the aromatic protons of MPDL (at 7.2 ppm).</s><s>The presence of Gem was quantitatively conrmed by <ref type="bibr" target="#b18">19</ref> F NMR by comparing the integration of the uorine atoms of the internal standard PFCE (d ¼ À88 ppm) and of Gem (d ¼ À117 ppm).</s></p><p><s>Synthesis of low molar mass Gem-digly-poly(methyl methacrylate)-co-(2-methylene-4-phenyl-1,3-dioxolane) (Gem-digly-P(MMA-co-MPDL)).</s><s>Copolymers with a targeted M n of $10 000 g mol À1 were prepared by following a similar procedure to that of expt 4 but with a polymerization time of 5 h.</s><s>Experimental conditions were as follows: P4d (f MPDL,0 ¼ 0.2) [MMA (1.0673 g, 10.67 mmol), MPDL (0.4327 g, 2.67 mmol), Gem-digly-AMA-SG1 (152.0 mg, 1.52 Â 10 À1 mmol), SG1 (5.2 mg, 1.52 Â 10 À2 mmol) and anhydrous toluene (1.5 g, 1.73 mL)] for P5d (f MPDL,0 ¼ 0.4) [MMA (0.7215 g, 7.22 mmol), MPDL (0.7785 g, 4.81 mmol), Gem-digly-AMA-SG1 (100.0 mg, 9.99 Â 10 À2 mmol), SG1 (3.4 mg, 9.95 Â 10 À3 mmol) and anhydrous toluene (1.5 g, 1.73 mL)] and for P6d (f MPDL,0 ¼ 0.7) [MMA (0.3135 g, 3.14 mmol), MPDL (1.1865 g, 7.32 mmol), Gemdigly-AMA-SG1 (25 mg, 2.50 Â 10 À2 mmol), SG1 (0.9 mg, 2.63 Â 10 À3 mmol) and anhydrous toluene (1.5 g, 1.73 mL)].</s><s>The nal composition of the prodrug was determined by comparing the methyl protons in the a-position to the ester group of MMA (at 3.7 ppm) to the aromatic protons of MPDL (at 7.2 ppm).</s><s>The presence of Gem was quantitatively conrmed by <ref type="bibr" target="#b18">19</ref> F NMR by comparing the integration of the uorine atoms of the internal standard PFCE (d ¼ À88 ppm) and of Gem (d ¼ À117 ppm).</s></p><p><s>Synthesis of low molar mass Gem-poly[(methyl methacrylate)-co-styrene] (Gem-P(MMA-co-S)).</s><s>Polymer prodrugs without MPDL with a targeted M n of $10 000 g mol À1 were prepared by following a similar procedure to that of expt 4 but with a polymerization time of 5 h.</s><s>Experimental conditions were as follows: MMA (1.3393 g, 13.39 mmol), S (0.1607 g, 15.45 mmol), Gem-AMA-SG1 (2.81 mg, 4.59 Â 10 À2 mmol), and anhydrous toluene (1.5 g, 1.73 mL).</s><s>SEC:</s></p><formula xml:id="formula_2">M n ¼ 9751 g mol À1 , M w /M n ¼ 1.33.</formula><p><s>Synthesis of low molar mass poly[(methyl methacrylate)co-(2-methylene-4-phenyl-1,3-dioxolane)] (P(MMA-co-MPDL)).</s></p><p><s>Copolymers without Gem P8 with a targeted M n of $10 000 g mol À1 and f MPDL,0 ¼ 0.7 were prepared by following a similar procedure to that of expt 4 but with a polymerization time of 5 h.</s><s>Experimental conditions were as follows: MMA (0.3604 g, 3.60 mmol), MPDL (0.4010 g, 2.47 mmol), BlocBuilder MA (16.0 mg, 4.20 Â 10 À2 mmol), and anhydrous toluene (0.77 g, 0.89 mL).</s><s>The nal composition of the copolymer was determined by comparing the methyl protons in the a-position to the ester group of MMA (at 3.7 ppm) to the aromatic protons of MPDL (at 7.2 ppm).</s><s>SEC:</s></p><formula xml:id="formula_3">M n ¼ 9100 g mol À1 , M w /M n ¼ 1.26. 1 H NMR: F MPDL ¼ 0.17.</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Deprotection of the copolymers</head><p><s>Deprotection of Gem-digly-P(OEGMA-co-MPDL).</s><s>The TBDMS-protected Gem-digly-P(OEGMA-co-MPDL) copolymer (100 mg) was dissolved in 0.5 mL THF and TBAF (1 M in THF, 50 mL) was added.</s><s>The solution was allowed to stir for 30 min and the solvent was removed under reduced pressure.</s><s>Aer solubilization in 2 mL of DCM, the organic phase was washed twice with brine, precipitated in a mixture of cold cyclohexane/petroleum ether (1/1, v/v) and dried under reduced pressure.</s><s>The copolymers were analyzed by <ref type="bibr" target="#b0">1</ref> H NMR and SEC.</s><s>NMR analysis showed complete disappearance of TBDMS protecting groups (Fig. <ref type="figure" target="#fig_3">S2 †</ref>) and <ref type="bibr" target="#b18">19</ref> F NMR conrmed the quantitative presence of Gem.</s></p><p><s>Deprotection of Gem-digly-P(MMA-co-MPDL).</s><s>The TBDMSprotected copolymer Gem-digly-P(MMA-co-MPDL) (100 mg) was dissolved in 0.5 mL THF and TBAF (1 M in THF, 50 mL) was added.</s><s>The solution was allowed to stir for 30 min before pouring into 10 mL of MeOH.</s><s>The copolymer was then precipitated using cold MeOH and dried under high vacuum.</s><s>Polymers were analyzed by <ref type="bibr" target="#b0">1</ref> H NMR and SEC.</s><s>NMR analysis showed complete disappearance of TBDMS protecting groups (Fig. <ref type="figure" target="#fig_4">S3 †</ref>) and <ref type="bibr" target="#b18">19</ref> F NMR conrmed the quantitative presence of Gem.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hydrolytic degradation</head><p><s>Hydrolytic degradation of Gem-P(OEGMA-co-MPDL).</s><s>In a 5 mL vial, 50 mg of copolymer was dissolved in 5 mL of 5% KOH aqueous solution and stirred at room temperature.</s><s>Samples (1 mL) were periodically taken, neutralized with 1 M HCl aqueous solution and lyophilized.</s><s>2 mL of chloroform was then added, allowing ltration of the salts.</s><s>Finally, the solvent was removed under reduced pressure and the degradation products were analyzed by SEC.</s></p><p><s>Hydrolytic degradation of Gem-P(MMA-co-MPDL).</s><s>In a 5 mL vial, 50 mg of copolymer was dissolved in 2.5 mL of THF.</s><s>Aer solubilization, 2.5 mL of potassium hydroxide solution (KOH, 10%) in methanol was added.</s><s>The cloudy mixture was stirred at room temperature.</s><s>Samples (1 mL) were periodically taken, immediately dried under vacuum and 2 mL of chloroform was added, allowing ltration of the salts.</s><s>Finally, the solvent was removed under reduced pressure and the degradation products were analyzed by SEC.</s><s>Note that the carboxylic acid chain ends aer degradation can be responsible for aggregation of polymer chains during SEC analysis, resulting in larger apparent M n .</s><s>This problem was resolved by adding 0.1% (w/w) of TFA in both the eluent and the sample.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Nanoparticle preparation</head><p><s>Nanoparticles were prepared by the nanoprecipitation technique. <ref type="bibr" target="#b54">55</ref></s><s>For Gem-P(MMA-co-MPDL) and Gem-digly-P(MMA-co-MPDL), 2 mg of copolymer was dissolved in 2 mL of THF, and added dropwise to 4 mL MilliQ water under stirring.</s><s>For Gem-P(OEGMA-co-MPDL) and Gem-digly-P(OEGMA-co-MPDL), 2.5 mg of copolymer was dissolved in 0.5 mL of THF, and added dropwise to 1 mL MilliQ water under stirring.</s><s>In all cases, THF was evaporated at ambient temperature using a Rotavapor.</s><s>Average diameter (D z ) and zeta potential (z) measurements were carried out in triplicate.</s><s>For stability studies, the different samples were either dropped in water or PBS, or diluted in complete cell culture medium to reach a nal concentration of 0.25 mg mL À1 .</s><s>Samples were kept at 4 C and allowed to warm to room temperature before each measurement which was performed in triplicate at 25 C.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Nanoprecipitation yield</head><p><s>The amount of Gem-P(OEGMA-co-MPDL) nanoparticles formed by nanoprecipitation was determined as follows.</s><s>A minimal amount of 4 mL of nanoparticle suspension (corresponding at least to 10 mg of copolymer) was ultracentrifuged (40 000 rpm, 4 h, 4 C).</s><s>The supernatant and the pellet were separated and freeze-dried.</s><s>The weight fraction of nanoparticles formed aer nanoprecipitation was calculated according to: w nanoparticles ¼ m pellet /(m pellet + m supernantant ).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Drug release kinetics</head><p><s>To determine the release kinetics of Gem, 1.5 mL of Gem-P(OEGMA-co-MPDL) P1-P3 and P1d-P3d (0.5 mg mL À1 ) or Gem-P(MMA-co-MPDL) P4-P6 and P4d-P6d (0.5 mg mL À1 ) nanoparticles were added to 1.5 mL of human serum solution supplemented with 200 mg mL À1 tetrahydrouridine (THU). <ref type="bibr" target="#b57">56,</ref><ref type="bibr" target="#b58">57</ref></s><s>he mixture was incubated at 37 C and aliquots (600 mL) of incubation medium were withdrawn at different time points (1, 4, 8 and 24 h), spiked with 60 mL of 10 mM theophylline (Internal Standard, IS) before addition of 1 mL of a mixture of acetonitrile/methanol (90/10, v/v) and ultracentrifuged (15 000 g, 20 min, 4 C).</s><s>The supernatant was then evaporated to dryness under a nitrogen ow at 30 C. The released native drug was quantied by reverse-phase HPLC (Waters, Milford, MA 01757, USA) with a C18 column.</s><s>To ensure that only native Gem was quantied, the calibration curve was carried out using native Gem (elution time ¼ 10.6 min).</s><s>For drug-release experiments, only this peak was integrated to determine native Gem content.</s><s>Briey, the chromatographic system consisted of a Waters 1525 Binary HPLC pump, a Waters 2707 Autosampler, a C18 Uptisphere column (3 mm, 150 Â 4.6 mm; Interchim), HPLC column temperature controllers (model 7950 column heater and chiller; Jones Chromatography, Lakewood, CO), and a Waters 2998 programmable photodiode-array detector.</s><s>The HPLC column was maintained at 30 C and detection was monitored at 270 nm.</s><s>The HPLC mobile phase consisted of a mixture of methanol and water with 0.05 M sodium acetate (pH 5.0, eluent A: 5/95, v/v; eluent B 97/3, v/v).</s><s>The residues were dissolved in 100 mL of eluent A. Elution was performed at a ow rate of 0.8 mL min À1 isocratically for 8 min with eluent A followed by a linear gradient (1 min) to 100% eluent B. This was followed by a 15 min hold at eluent B and a 1 min linear gradient back to 100% eluent A. The system was held for 6 min for equilibration back to initial conditions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Biological evaluation</head><p><s>Cell lines and cell culture.</s><s>Human pancreatic cancer cell line MiaPaCa-2 and human lung carcinoma cell line A549 were obtained from the American Type Culture Collection.</s><s>All cell lines were maintained as recommended.</s><s>Briey, A549 and MiaPaCa-2 cells were grown in Dulbecco's minimal essential medium (DMEM).</s><s>All media were supplemented with 10% heatinactivated FBS (56 C, 30 min), penicillin (100 U mL À1 ) and streptomycin (100 mg mL À1 ).</s><s>Medium for MiaPaCa-2 cell line was supplemented with 2.5% heat-inactivated (56 C, 30 min) horse serum (Gibco).</s><s>Cells were maintained in a humid atmosphere at 37 C with 5% CO 2 .</s></p><p><s>In vitro anticancer activity.</s><s>MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] was used to evaluate the cytotoxicity of the different polymer prodrugs.</s><s>Briey, cells (5 Â 10 3 per well) were seeded in 96-well plates.</s><s>Aer overnight incubation, the cells were then exposed to a series of concentrations of polymer prodrugs, control polymers or free Gem for 72 h (A549 cells) or 120 h (MiaPaCa-2 cells).</s><s>20 mL of MTT solution (5 mg mL À1 in PBS) was then added to each well.</s><s>The plates were incubated for 1 h at 37 C and the medium was removed.</s><s>200 mL of DMSO was then added to each well to dissolve the precipitates.</s><s>Absorbance was measured at 570 nm using a plate reader (Metertech S 960, Fisher Bioblock, Illkirch, France).</s><s>The percentage of surviving cells was calculated as the absorbance ratio of treated to untreated cells.</s><s>The inhibitory concentration 50% (IC 50 ) of the treatments was determined from the dose-response curve.</s><s>All experiments were set up in sextuplicate to determine means and SDs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results and discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthetic strategy</head><p><s>To illustrate our approach, gemcitabine (Gem, 2 0 -deoxy-2 0 ,2 0 -diuorocytidine) was selected as an anticancer drug.</s><s>Gem is a nucleoside analog approved for the treatment of various solid tumors including lung, pancreatic, breast, or ovarian cancers. <ref type="bibr" target="#b59">58</ref></s><s>owever, severe limitations restrict its clinical use and drastically reduce its efficacy: (i) short plasma half-life and rapid renal excretion due to rapid deamination by deoxycitidine deaminase, (ii) induction of resistances owing to inhibition of transmembrane transporter nucleoside, and (iii) severe side effects as a result of frequent administration schedule.</s><s>Therefore, new prodrug strategies applied to Gem are of high importance in the eld of nanomedicine.</s></p><p><s>This new class of polymer prodrugs was synthesized by nitroxide-mediated radical ring-opening copolymerization (NMrROP) between a methacrylic ester and 2-methylene-4phenyl-1,3-dioxolane (MPDL) as a CKA, from a Gemfunctionalized alkoxyamine initiator (Fig. <ref type="figure" target="#fig_1">1</ref>).</s><s>]<ref type="bibr" target="#b62">[61]</ref> To establish structure-activity relationships and obtain polymer prodrugs with the highest activity against cancer cells, various structural parameters were varied such as the nature of the methacrylic ester, the composition of the copolymer and the nature of the drug-copolymer linker (Fig. <ref type="figure" target="#fig_3">2</ref>).</s><s>More specically, two different methacrylic ester monomers were copolymerized with MPDL: either oligo(ethylene glycol) methyl ether methacrylate (OEGMA) as a hydrophilic monomer or methyl methacrylate (MMA) as a hydrophobic one (Fig. <ref type="figure" target="#fig_3">2a and c</ref>).</s></p><p><s>Copolymerizations were initiated by two different alkoxyamines based on the SG1 nitroxide, which only differed in the nature of the linker between Gem and the alkoxyamine moiety: an amide bond (Gem-AMA-SG1) or an amide bond connected to a labile diglycolate linker (Gem-digly-AMA-SG1) (Fig. <ref type="figure" target="#fig_3">2b</ref>).</s><s>Variable initial amounts of MPDL were also investigated to confer the resulting polymer prodrugs with distinct levels of degradability.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthesis of Gem-based alkoxyamine initiators</head><p><s>Given its susceptibility to deamination, <ref type="bibr" target="#b63">62</ref> Gem was derivatized through its C-4 amino group.</s><s>Gem-AMA-SG1 was synthesized by direct coupling between unprotected Gem and AMA-SG1 using PyBOP as a coupling agent.</s><s>For Gem-digly-AMA-SG1, the best conditions were obtained via protection of the two hydroxyl groups with TBDMSCl, followed by PyBOP-assisted coupling of the resulting TBDMSGem with AMA-digly-SG1 (Fig. <ref type="figure" target="#fig_3">2b</ref>).</s><s>The expected product (Fig. <ref type="figure" target="#fig_1">S1 †</ref>) was obtained with a coupling yield of 63%.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Copolymerization kinetics</head><p><s>A comprehensive kinetic study was rst performed to investigate the inuence of the different parameters on the control of the copolymerization.</s><s>Gem-AMA-SG1 or Gem-digly-AMA-SG1 alkoxyamines were used to initiate the NMrROP of OEGMA (expts 1-3 and 1d-3d, Fig. <ref type="figure" target="#fig_4">3</ref>) or MMA (expts 4-6 and 4d-6d, Fig. <ref type="figure" target="#fig_5">4</ref>) in the presence of variable initial fractions of MPDL (f MPDL,0 ¼ 0.2-0.7) at 90 C in 50 wt% toluene.</s><s>In all cases, the higher the initial fraction of MPDL, the better the control of the copolymerization.</s><s>For f MPDL,0 ¼ 0.2, regardless of the methacrylic ester used (expts 1, 1d, 4 and 4d), the copolymerizations did not exhibit a rst order kinetics while M n values hardly increased with conversion and were much higher than the theoretical ones with rather high dispersities aer 50% conversion, thus indicating a partial control.</s><s>Such a low initial amount of MPDL was therefore not sufficient for efficient insertion of MPDL in the copolymer (according to the reactivity ratios) to prevent irreversible termination reactions.</s><s>For f MPDL,0 ¼ 0.4, (expts 2, 2d, 5 and 5d), the control over the polymerization was signicantly improved, leading to nearly rst order kinetics, linear increase of M n with conversion, exhibiting values closer to the theoretical ones, and lower dispersities even at high conversion for expts 4-6 and 4d-6d.</s><s>Control was further enhanced for f MPDL,0 ¼ 0.7 (expt 3, 3d, 6 and 6d).</s></p><p><s>Interestingly, the control was generally better when the copolymerization was initiated by Gem-digly-AMA-SG1 compared to those initiated by Gem-AMA-SG1.</s><s>M n values and dispersities at high conversions were indeed systematically lower with Gem-digly-AMA-SG1.</s><s>This trend can be explained by the structure of the alkoxyamines and its inuence on its dissociation rate constant and subsequently on the control of the polymerization.</s><s>Conversely to Gem-digly-AMA-SG1, Gem-AMA-SG1 is prone to intramolecular hydrogen-bonding (IHB) between the hydrogen of the amide from the propagating radical and the nitroxide fragment. <ref type="bibr" target="#b64">63</ref></s><s>It resulted in slower dissociation kinetics and thus a less efficient control because of the lower amount of released nitroxide.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Synthesis of low molar mass polymer prodrugs for biological evaluations</head><p><s>One of the main benets of the drug-initiated method is the facile tuning of the drug loading simply by varying the M n of the polymer, which is of great importance for further biological evaluation.</s><s>Herein, we targeted lower molar mass polymer prodrugs (M n $10 000 g mol À1 ) to obtain a drug loading of $2.5 wt% by adapting the reaction conditions (e.g., lower reaction times and/or lower targeted M n , see the Experimental part).</s><s>Note that, if needed, higher drug loadings can be successfully obtained (e.g., 3.6 and 9.0 wt%) by further decreasing the M n (P3 0 and P3 00 , Table <ref type="table" target="#tab_1">S1</ref> †).</s><s>Four libraries of well-dened copolymer prodrugs from each series were prepared (Table <ref type="table" target="#tab_1">1</ref> and Fig. <ref type="figure" target="#fig_5">S4 †</ref>): Gem-P(OEGMA-co-MPDL) (P1-P3), Gem-digly-P(OEGMA-co-MPDL) (P1d-P3d), Gem-P(MMA-co-MPDL) (P4-P6) and Gem-digly-P(MMA-co-MPDL) (P4d-P6d).</s><s>A lower reaction time also enabled improving the control by avoiding high monomer conversion and thus extensive occurrence of irreversible termination reactions.</s><s>Overall, dispersities of the resulting copolymers ranged from 1.1 to 1.4, except for P1 whose control was difficult to achieve given the very low amount of initial MPDL <ref type="bibr" target="#b60">59</ref> and the use of the less efficient alkoxyamine (as detailed in the previous section). <ref type="bibr" target="#b0">1</ref></s><s>H NMR spectroscopy of the puried copolymers (and deprotected for P1d-P6d) in CDCl 3 (Fig. <ref type="figure" target="#fig_6">S5</ref>-S8 †) and in DMSO-d 6 (Fig. <ref type="figure" target="#fig_10">S9</ref>-S12 †) showed all signals expected for each structure. <ref type="bibr" target="#b18">19</ref></s><s>F NMR spectroscopy conrmed the quantitative presence of Gem at the extremity of the copolymers.</s><s>Despite unfavorable reactivity ratios of the different monomer pairs (rMPDL ¼ 0 and rOEGMA ¼ 6.95, <ref type="bibr" target="#b60">59</ref> and rMPDL ¼ 0.01 and rMMA ¼ 4.0 (ref.</s><s>54)), the molar fraction of MPDL in the copolymer (F MPDL ) was nely tuned by varying the initial molar fraction of MPDL in the comonomer feed (Table <ref type="table" target="#tab_1">1</ref>) to induce different levels of degradability.</s><s>On average, F MPDL was $0.07 for f MPDL,0 ¼ 0.2, $0.13 for f MPDL,0 ¼ 0.4 and $0.26 for f MPDL,0 ¼ 0.7.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hydrolytic degradation of the prodrugs</head><p><s>The degradation of the different copolymer prodrugs was then evaluated under accelerated conditions to probe the presence of the ester group in the polymer backbone, that is at room temperature in 5% KOH, either in water for OEGMA-based copolymers (P1-P3) or in a THF/MeOH (50 : 50, v/v) mixture for MMA-based copolymers (P4-P6).</s><s>As expected, control copolymers without MPDL (F MPDL ¼ 0), Gem-P(OEGMA-co-S) and Gem-P(MMA-co-S), did not undergo any degradation as shown by their constant M n over time.</s><s>Conversely, MPDL-containing copolymer prodrugs led to adjustable degradation in direct relationship with their MPDL content, as shown by the shis of the SEC chromatograms towards lower M n values (Fig. <ref type="figure" target="#fig_5">S13 and S14 †</ref>).</s><s>Whatever the nature of the methacrylic ester, the higher the MPDL content, the greater the degradation.</s><s>The M n decrease (Fig. <ref type="figure" target="#fig_6">5</ref>) spanned from 10 to 30% for copolymers with the lowest MPDL contents (P1 and P4) to $70% for those with the highest amounts of MPDL (P3 and P6).</s><s>These results conrmed the signicant insertion of open MPDL units in the main chain of the copolymers and the possibility to ne-tune their degradation by adjusting the initial comonomer stoichiometry.</s></p><p><s>Note that some discrepancy between theoretical M n aer degradation (calculated according to: 1/F MPDL À 1) and experimental ones may appear because of unfavorable reactivity ratios, as commonly observed with CKA monomers. <ref type="bibr" target="#b60">59</ref></s><s>Also, molar mass distributions stayed rather low (Đ $1.5-1.8)</s><s>aer degradation, which is in agreement with a theoretical investigation <ref type="bibr" target="#b65">64</ref> showing that stopping at low conversion for the synthesis of the copolymers is key to maintaining a certain homogeneity of the degraded products.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Physicochemical properties</head><p><s>Given their hydrophobic backbone and the water-solubility of Gem, Gem-P(MMA-co-MPDL) (P4-P6) and Gem-digly-P(MMA-co-MPDL) (P4d-P6d) prodrugs were formulated into nanoparticles in water.</s><s>They displayed an average diameter in the 109-196 nm range, along with narrow particle size distributions (Table <ref type="table" target="#tab_2">2</ref>) and great colloidal stability in the long run either in water or in cell culture medium (Fig. <ref type="figure" target="#fig_6">S15 †</ref>), whereas poor colloidal stability was observed in PBS.</s><s>Interestingly, nanoparticles prepared from P4d-P6d were signicantly smaller than those prepared from P4-P6, possibly because of the additional hydrophilicity provided by the diglycolate linker, promoting Gem positioning at the surface of the nanoparticles and thus inducing a more efficient stabilization.</s><s>This hypothesis is supported by the increase of the predicted HLB number for a model Gem-digly-PMMA prodrug compared to Gem-PMMA using both the Davies and the Griffin methods (Table <ref type="table" target="#tab_2">S2</ref> †).</s><s>Representative Cryo-TEM images showed spherical morphologies in good agreement with DLS data (Fig. <ref type="figure" target="#fig_7">6a</ref> and b and Fig. <ref type="figure" target="#fig_7">S16</ref> and S17 †).</s><s>All nanoparticles exhibited great colloidal stability over time as shown by their constant size and size distributions for at least 25 days aer nanoprecipitation (Fig. <ref type="figure" target="#fig_7">6c</ref>).</s><s>Such an efficient colloidal stability is likely the result of an efficient electrostatic stabilization, as shown by the signicantly negative zeta potential measurements (Table <ref type="table" target="#tab_2">2</ref>).</s></p><p><s>Given the relatively moderate F MPDL values for P(OEGMA-co-MPDL) copolymers, the water-solubility of OEGMA was expected to dominate over the hydrophobicity from MPDL units, and thus preferentially lead to fully water-soluble polymer prodrugs.</s><s>To validate this hypothesis, Gem-P(OEGMA-co-MPDL) prodrugs with increasing contents of MPDL (P1-P3) were nanoprecipitated in water and the amount of nanoparticles, likely formed by nanoscale aggregation of amphiphilic P(OEGMA-co-MPDL) copolymers, was quantied by measurement of the dry content aer ultracentrifugation (see the Experimental part and Table <ref type="table">S3</ref> †).</s><s>The weight fraction of nanoparticles was estimated to be 16 wt% maximum for the copolymer containing the highest amount of MPDL (F MPDL ¼ 0.25) to less than 1 wt% for the one with the lowest amount (F MPDL ¼ 0.06).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Drug release in human serum</head><p><s>The Gem release kinetics from the two different classes of polymer prodrugs was evaluated in human serum to better mimic the biological environment of the human body compared to accelerated degradation conditions (Fig. <ref type="figure" target="#fig_8">7</ref>).</s><s>In all cases, the maximum drug release was reached aer a period of $1 h which is rather fast but commonly seen with water-soluble amide prodrugs. <ref type="bibr" target="#b66">65</ref></s><s>It is also believed that having a hydrophilic drug like Gem promotes fast drug release compared to hydrophobic ones, for instance like paclitaxel, as already observed. <ref type="bibr" target="#b11">12</ref></s><s>nterestingly, aer the maximum drug release is reached, a plateau is observed which likely corresponds to the fraction of drug that is not easily accessible and that cannot be readily cleaved from the copolymers within the time frame of the drug release experiment.</s><s>We can hypothesize for P(MMA-co-MPDL) nanoparticles that only the surface fraction of Gem is released whereas the fraction which is buried into the nanoparticle's core will be accessible and released only when the nanoparticles are degraded. <ref type="bibr" target="#b67">66</ref></s><s>As for soluble P(OEGMA-co-MPDL) prodrugs, which are essentially molecularly dissolved even for the highest amounts of MPDL (Fig. <ref type="figure" target="#fig_9">S18 †</ref>), they will form a protective P(OEGMA-co-MPDL) shroud wrapped around the drug, efficiently protecting the drug-linker moiety from enzymes, similarly to what is observed with PEGylated peptides/proteins.</s><s>Therefore, only the fraction of Gem located at the periphery of such a PEG-based random coil will be readily cleaved whereas the remaining amount of drug will be accessible aer the copolymer gets degraded. <ref type="bibr" target="#b67">66</ref></s><s>or Gem-P(OEGMA-co-MPDL) P1-P3, the total Gem release gradually increased from $7 to $25% when decreasing F MPDL from 0.25 to 0.06 (Fig. <ref type="figure" target="#fig_8">7a</ref>).</s><s>This may be explained by the strong hydrophobic nature of MPDL that prevents enzyme access because of poor solvation of the drug-polymer linker and/or pp stacking interactions between MPDL units.</s><s>Analogous copolymers with the diglycolate linker (P1d-P3d) led to the same trend but with a signicantly higher Gem release; from $33% for F MPDL ¼ 0.22 to $70% for F MPDL ¼ 0.07 (Fig. <ref type="figure" target="#fig_8">7b</ref>), likely because of the increased hydrophilicity and decreased steric  hindrance in the vicinity of the amide bond.</s><s>Replacing OEGMA by MMA in the polymer prodrug structures (P4-P6 and P4d-P6d) led to the exact same trend but with signicantly lower Gem release contents.</s><s>Gem-P(MMA-co-MPDL) nanoparticles P4-P6 led to nearly no Gem release (&lt;2%) whereas Gem-digly-P(MMA-co-MPDL) nanoparticles (P4d-P6d) allowed nal Gem release contents to reach 7-13% (Fig. <ref type="figure" target="#fig_8">7c and d</ref>).</s><s>This may be explained not only by the detrimental effect of hydrophobic MMA units in the vicinity of the Gem-polymer linker, but also by the nanoparticulate nature of the polymer prodrug itself, both preventing extensive water uptake and/or enzyme access.</s><s>Altogether, these results showed that Gem release was independently governed by: (i) the MPDL contentthe lower the MPDL content, the greater the Gem release; (ii) the nature of the  linkerthe presence of the diglycolate linker enabled a greater Gem release compared to a simple amide bond and (iii) the hydrophilicity of the methacrylate monomer-OEGMA enabled a greater Gem release compared to MMA.</s><s>It is therefore suggested that increasing the hydrophilicity in the vicinity of the drug-polymer linkage, by using OEGMA and/or by decreasing the amount of inserted MPDL, which is a strongly hydrophobic monomer, had a benecial inuence on the Gem release.</s><s>Regarding the diglycolate linker, its benecial impact may be explained by: (i) its higher lability compared to a single amide bond that may enable its rapid cleavage and (ii) its connection to the amide bond that may promote the amide bond accessibility to enzymes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vitro anticancer activity</head><p><s>A crucial question is whether the above-mentioned drug release trends observed in human serum directly correlate with the anticancer activity of the polymer prodrugs.</s><s>The cell viability of two cancer cell lines corresponding to clinically relevant cancer models for Gem, human lung carcinoma (A549) and human pancreatic cancer (MiaPaCa-2), was then determined aer incubation with the different polymer prodrugs at various concentrations.</s></p><p><s>Gem-free control copolymers, P(OEGMA-co-MPDL) P7 and P(MMA-co-MPDL) P8, were not cytotoxic for all concentrations tested while free Gem exhibited half maximal inhibitory concentrations (IC 50 ) of 4 nM and 14 nM for A549 and MiaPaCa-2 cells, respectively.</s><s>When increasing the MPDL fraction, IC 50 values of Gem-P(OEGMA-co-MPDL) P1-P3 increased from 0.30 to 2.14 mM for A549 cells and from 0.13 to 1.07 mM for MiaPaCa-2 cells (Fig. <ref type="figure" target="#fig_9">8</ref>), which is totally in line with the previously mentioned trends observed from drug release experiments.</s><s>As expected from drug release experiments, diglycolate-containing polymer prodrugs (P1d-P3d) gave the same trend but were signicantly more cytotoxic, leading to IC 50 values 5-8-fold lower for A549 cells (Fig. <ref type="figure" target="#fig_9">8a and b</ref>) to 3-4-fold lower for MiaPaCa-2 cells (Fig. <ref type="figure" target="#fig_9">8c and d</ref>) compared to those obtained from P1-P3.</s><s>Note that the small fraction of Gem-P(OEGMA-co-MPDL) nanoparticles present along with the soluble Gem-P(OEGMA-co-MPDL) copolymer did not affect the MTT results as a puried aqueous solution of copolymers P2 gave the same cytotoxicity prole (Fig. <ref type="figure" target="#fig_10">S19 †</ref>).</s></p><p><s>Also, in agreement with drug release experiments, Gem-P(MMA-co-MPDL) P4-P6 and Gem-digly-P(MMA-co-MPDL) P4d-P6d polymer prodrug nanoparticles (Fig. <ref type="figure" target="#fig_10">9</ref>) were always less cytotoxic than OEGMA-based counterparts.</s><s>Importantly, whatever the cell line, no decrease in cell viability was observed for P4-P6 even at the highest concentrations, whereas the use of the diglycolate linker made the corresponding prodrugs cytotoxic, especially for those containing less MPDL (P5d and P6d, see Fig. <ref type="figure" target="#fig_10">9b and d</ref>).</s><s>As suggested from drug release experiments, this trend may be correlated with a too high hydrophobicity in the vicinity of the Gem-polymer linker, but also with the nanoparticulate nature of the polymer prodrugs that, conversely to fully water-soluble counterparts, were less accessible to water/enzymes, thus preventing efficient release of Gem (only surface exposed Gem-digly moieties were likely accessible for cleavage).</s><s>Note that, in general, higher cytotoxicity was observed against MiaPaCa-2 cells, with nearly complete cell death.</s><s>This is explained by the fact that A549 cells are known to exhibit some This journal is © The Royal Society of Chemistry 2018 resistance against Gem, as evidenced by a plateau at 20% of cell viability. <ref type="bibr" target="#b68">67</ref></s><s>Even though results with Gem-P(MMA-co-MPDL) and Gem-digly-P(MMA-co-MPDL) nanoparticles may appear somewhat disappointing, they are crucial to identify key structural parameters to improve the cytotoxicity of the materials.</s></p><p><s>In a nutshell, the results for both cell lines were in excellent agreement with those obtained from drug release experiments: (i) polymer prodrugs based on P(OEGMA-co-MPDL) were more cytotoxic than those based on P(MMA-co-MPDL); (ii) increasing the MPDL fraction in the copolymers led to a decrease in cytotoxicity and (iii) polymer prodrugs based on the diglycolate linker were signicantly more cytotoxic than those based on a single amide linkage (see Table <ref type="table">S4</ref> † for all IC 50 values).</s><s>Remarkably, the best candidate, Gem-digly-P(OEGMA-co-MPDL) P1d enabled reaching the cytotoxic activity of free Gem.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>Degradable vinyl polymer prodrugs were designed by "druginitiated" NMrROP of a methacrylic ester monomer with MPDL from an alkoxyamine derivatized with Gem as an anticancer drug.</s><s>Two libraries of polymer prodrugs differing by the nature of the methacrylic ester monomer (OEGMA or MMA), the nature of the drug-polymer linker and the MPDL content were prepared.</s><s>Whereas MMA-based prodrugs formed highly stable nanoparticles upon nanoprecipitation, OEGMA-based prodrugs were water-soluble.</s><s>The degradation of the copolymer prodrugs was proved under accelerated conditions (i.e., basic hydrolysis) and the degradation level was nely tuned by adjusting the MPDL content.</s><s>Drug-release proles in human serum and in vitro anticancer activity against two different cancer cell lines helped to establish structure/activity relationships and select the most favorable structural parameters for having the best activity.</s><s>We demonstrated that three structural parameters independently governed the anticancer activity: (i) soluble OEGMA-based prodrugs were more cytotoxic than MMA-based counterparts; (ii) the lower the MPDL content, the greater the anticancer activity and (iii) a diglycolate linker afforded greater activity compared to a simple amide bond.</s></p><p><s>Overall, this unique approach enabled us to combine the best of different worlds: (i) degradability from ring-opening polymerization; (ii) ease of synthesis by a radical polymerization method and (iii) sustained drug release and high anticancer activity by a prodrug approach.</s><s>Additionally, this approach is versatile and general as it could easily be extended to other polymers, to other pathologies by using different drugs, and to other biologically relevant molecules (e.g., uorescent dyes, imaging agents) for theranostic applications.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflicts of interest</head><p><s>There are no conicts to declare.</s><s>Denis (Institut Galien Paris-Sud) for technical assistance in HPLC and cell culture, respectively.</s><s>Arkema is warmly acknowledged for kindly providing the BlocBuilder MA™ alkoxyamine and the SG1 nitroxide.</s><s>The CNRS is also acknowledged for nancial support.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>4-amino-1-[4-(tert-butyl-dimethylsilanyloxy)-5-(tert-butyl-dimethyl-silanyloxymethyl)-3,3-diuorotetrahydro-furan-2-yl]-1H-pyrimidin-2-one (TBDMS-Gem), 15 alkoxyamines Gem-AMA-SG1 (ref.</s><s>10) and AMAdigly 11 were prepared as reported elsewhere.</s><s>Tetrabutylammonium</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1</head><label>1</label><figDesc><div><p><s>Fig.1Synthetic strategy for the design of degradable Gemcitabine-based polymer prodrugs by "drug-initiated" nitroxide-mediated radical ringopening copolymerization (NMrROP).</s></p></div></figDesc><graphic coords="2,127.28,521.12,340.76,179.55" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>This journal is © The Royal Society of Chemistry 2018 Chem.</s><s>Sci., 2018, 9, 8291-8306 | 8297 Edge Article Chemical Science Open Access Article.</s><s>Published on 13 September 2018.</s><s>Downloaded on 5/17/2022 11:58:43 PM.</s><s>This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 2</head><label>2</label><figDesc><div><p><s>Fig. 2 Synthesis of (a) Gem-P(OEGMA-co-MPDL) P1-P3 and Gem-P(MMA-co-MPDL) P4-P6 by NMrROP in toluene at 90 C, (b) Gem-digly-AMA-SG1 by PyBOP-assisted coupling between TBDMS-Gem and digly-AMA-SG1 and (c) Gem-digly-P(OEGMA-co-MPDL) P1d-P3d and Gemdigly-P(MMA-co-MPDL) P4d-P6d by NMrROP in toluene at 90 C followed by TBDMS group removal.</s></p></div></figDesc><graphic coords="8,52.04,50.57,491.21,496.12" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 3</head><label>3</label><figDesc><div><p><s>Fig. 3 NMrROP of OEGMA and MPDL in 50 wt% toluene at 90 C as a function of the nature of the alkoxyamine initiator [(a) and (b) Gem-AMA-SG1, (c) and (d) Gem-digly-AMA-SG1] and the initial fraction of MPDL: C expts 1 and 1d (f MPDL,0 ¼ 0.2),expts 2 and 2d (f MPDL,0 ¼ 0.4), : expts 3 and 3d (f MPDL,0 ¼ 0.7).</s><s>(a) and (c) ln[1/(1 À conv)] vs. time (conv ¼ OEGMA conversion).</s><s>Dashed lines connecting data points are guides for the eye only.</s><s>(b) and (d) Number-average molar mass, M n and dispersity, M w /M n , vs. conversion.</s><s>The dashed black line represents the theoretical M n .</s></p></div></figDesc><graphic coords="9,113.10,50.57,369.30,356.20" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig. 4</head><label>4</label><figDesc><div><p><s>Fig. 4 NMrROP of MMA and MPDL in 50 wt% toluene at 90 C as a function of the nature of the alkoxyamine initiator [(a) and (b) Gem-AMA-SG1, (c) and (d) Gem-digly-AMA-SG1] and the initial fraction of MPDL: C expts 4 and 4d (f MPDL,0 ¼ 0.2),expts 5 and 5d (f MPDL,0 ¼ 0.4), : expts 6 and 6d (f MPDL,0 ¼ 0.7).</s><s>(a) and (c) ln[1/(1 À conv)] vs. time (conv ¼ MMA conversion).</s><s>Dashed lines connecting data points are guides for the eye only.</s><s>(b) and (d) Number-average molar mass, M n and dispersity, M w /M n , vs. conversion.</s><s>The dashed black line represents the theoretical M n .</s></p></div></figDesc><graphic coords="10,113.10,50.57,369.30,356.32" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig. 5</head><label>5</label><figDesc><div><p><s>Fig. 5 Hydrolytic degradation under accelerated conditions (5% KOH) of the different degradable polymer prodrugs as a function of the MPDL fraction and the nature of the methacrylic ester monomer: (a) Gem-P(OEGMA-co-MPDL); C, control (F MPDL ¼ 0); :, P1 (F MPDL ¼ 0.06); -, P2 (F MPDL ¼ 0.12); ;, P3 (F MPDL ¼ 0.25).</s><s>(b) Gem-P(MMA-co-MPDL); C, control (F MPDL ¼ 0); :, P4 (F MPDL ¼ 0.10); -, P5 (F MPDL ¼ 0.19); ;, P6 (F MPDL ¼ 0.29).</s><s>Dashed lines are guides for the eye only.</s></p></div></figDesc><graphic coords="11,113.10,50.57,369.30,114.75" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Fig. 6</head><label>6</label><figDesc><div><p><s>Fig. 6 Representative Cryo-TEM images of (a) Gem-P(MMA-co-MPDL) P6 and (b) Gem-digly-P(MMA-co-MPDL) P6d nanoparticles.</s><s>(c) Evolution with time of the average diameter and the particle size distribution (PSD) of Gem-P(MMA-co-MPDL) (P4-P6) and Gem-digly-P(MMAco-MPDL) (P4d-P6d) nanoparticles in water determined by DLS.</s></p></div></figDesc><graphic coords="12,127.28,50.57,340.76,227.96" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Fig. 7</head><label>7</label><figDesc><div><p><s>Fig. 7 Gem release profiles at 37 C in human serum from (a) Gem-P(OEGMA-co-MPDL) (P1-P3), (b) Gem-digly-P(OEGMA-co-MPDL) (P1d-P3d), (c) Gem-P(MMA-co-MPDL) (P4-P6) and (d) Gem-digly-P(MMA-co-MPDL) (P4d-P6d).</s></p></div></figDesc><graphic coords="12,127.28,453.49,340.76,247.18" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Fig. 8</head><label>8</label><figDesc><div><p><s>Fig. 8 Cell viability (MTT test) with increasing concentrations of (a and c) Gem, Gem-P(OEGMA-co-MPDL) (P1-P3) and P(OEGMA-co-MPDL) (P7, control) or (b and d) Gem, Gem-digly-P(OEGMA-co-MPDL) (P1d-P3d) and P(OEGMA-co-MPDL) (P7, control) on (a and b) A549 cells and (c and d) MiaPaCa-2 cells.</s></p></div></figDesc><graphic coords="13,127.28,431.26,340.76,259.48" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head>Fig. 9</head><label>9</label><figDesc><div><p><s>Fig. 9 Cell viability (MTT test) with increasing concentrations of (a and c) Gem, Gem-P(MMA-co-MPDL) (P4-P6) and P(MMA-co-MPDL) (P8, control) or (b and d) Gem, Gem-digly-P(MMA-co-MPDL) (P4d-P6d) and P(MMA-co-MPDL) (P8, Control) on (a and b) A549 cells and (c and d) MiaPaCa-2 cells.</s></p></div></figDesc><graphic coords="14,127.28,50.57,340.76,259.60" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1</head><label>1</label><figDesc><div><p><s>Experimental conditions and macromolecular properties of Gem-based P(OEGMA-co-MPDL) and P(MMA-co-MPDL) polymer prodrugs</s></p></div></figDesc><table><row><cell>Prodrug</cell><cell>Alkoxyamine</cell><cell>Methacrylic ester</cell><cell>f MPDL,0</cell><cell>Conv. a (%)/temps (h)</cell><cell>M n b (g mol À1 )</cell><cell>Total DP n</cell><cell>Đ b</cell><cell>F MPDL c</cell></row><row><cell>P1</cell><cell>Gem-AMA-SG1</cell><cell>OEGMA</cell><cell>0.2</cell><cell>40/8</cell><cell>15 500</cell><cell>51</cell><cell>1.54</cell><cell>0.06</cell></row><row><cell>P2</cell><cell>Gem-AMA-SG1</cell><cell>OEGMA</cell><cell>0.4</cell><cell>28/8</cell><cell>10 200</cell><cell>34</cell><cell>1.39</cell><cell>0.12</cell></row><row><cell>P3</cell><cell>Gem-AMA-SG1</cell><cell>OEGMA</cell><cell>0.7</cell><cell>18/8</cell><cell>10 000</cell><cell>35</cell><cell>1.37</cell><cell>0.25</cell></row><row><cell>P1d</cell><cell>Gem-digly-AMA-SG1</cell><cell>OEGMA</cell><cell>0.2</cell><cell>61/8</cell><cell>11 500</cell><cell>36</cell><cell>1.24</cell><cell>0.07</cell></row><row><cell>P2d</cell><cell>Gem-digly-AMA-SG1</cell><cell>OEGMA</cell><cell>0.4</cell><cell>36/8</cell><cell>13 200</cell><cell>43</cell><cell>1.24</cell><cell>0.11</cell></row><row><cell>P3d</cell><cell>Gem-digly-AMA-SG1</cell><cell>OEGMA</cell><cell>0.7</cell><cell>22/8</cell><cell>11 200</cell><cell>38</cell><cell>1.13</cell><cell>0.22</cell></row><row><cell>P4</cell><cell>Gem-AMA-SG1</cell><cell>MMA</cell><cell>0.2</cell><cell>35/5</cell><cell>13 200</cell><cell>119</cell><cell>1.27</cell><cell>0.10</cell></row><row><cell>P5</cell><cell>Gem-AMA-SG1</cell><cell>MMA</cell><cell>0.4</cell><cell>34/5</cell><cell>9900</cell><cell>83</cell><cell>1.28</cell><cell>0.19</cell></row><row><cell>P6</cell><cell>Gem-AMA-SG1</cell><cell>MMA</cell><cell>0.7</cell><cell>23/5</cell><cell>10 300</cell><cell>82</cell><cell>1.21</cell><cell>0.29</cell></row><row><cell>P4d</cell><cell>Gem-digly-AMA-SG1</cell><cell>MMA</cell><cell>0.2</cell><cell>56/8</cell><cell>15 400</cell><cell>138</cell><cell>1.34</cell><cell>0.07</cell></row><row><cell>P5d</cell><cell>Gem-digly-AMA-SG1</cell><cell>MMA</cell><cell>0.4</cell><cell>55/8</cell><cell>12 400</cell><cell>106</cell><cell>1.29</cell><cell>0.12</cell></row><row><cell>P6d</cell><cell>Gem-digly-AMA-SG1</cell><cell>MMA</cell><cell>0.7</cell><cell>33/8</cell><cell>10 900</cell><cell>84</cell><cell>1.20</cell><cell>0.29</cell></row></table><note><p><s>1 Methacrylic ester conversion determined by1H NMR.</s><s>b Determined by SEC aer precipitation. c</s><s>Determined by 1 H NMR.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2</head><label>2</label><figDesc><div><p><s>Characterization of Gem-P(MMA-co-MPDL) and Gem-digly-P(MMA-co-MPDL) nanoparticles</s></p></div></figDesc><table><row><cell>Prodrug</cell><cell>D z a (nm)</cell><cell>PSD a</cell><cell>z b (mV)</cell><cell>% Gem c (wt%)</cell></row><row><cell>P4</cell><cell>196</cell><cell>0.09</cell><cell>À55</cell><cell>2.0</cell></row><row><cell>P5</cell><cell>162</cell><cell>0.10</cell><cell>À57</cell><cell>2.6</cell></row><row><cell>P6</cell><cell>174</cell><cell>0.09</cell><cell>À55</cell><cell>2.5</cell></row><row><cell>P4d</cell><cell>109</cell><cell>0.13</cell><cell>À37</cell><cell>1.7</cell></row><row><cell>P5d</cell><cell>110</cell><cell>0.11</cell><cell>À38</cell><cell>2.1</cell></row><row><cell>P6d</cell><cell>117</cell><cell>0.10</cell><cell>À46</cell><cell>2.4</cell></row></table><note><p><s>a Determined by DLS.</s><s>b Zeta potential, determined using the DLS apparatus.</s><s>c Determined according to: % Gem ¼ M w,Gem /M n,SEC .</s><s>This journal is © The Royal Society of Chemistry 2018 Chem.</s><s>Sci., 2018, 9, 8291-8306 | 8301</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">This journal is © The Royal Society of Chemistry 2018</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">View Article Online</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank the French Ministry of Research for the nancial support of the PhD thesis of EG and the French National Research Agency (ANR-11-JS08-0005 and ANR-15-CE08-0019) for the nancial support of the Master internship and PhD of JT, respectively.</s><s>The authors thank Julie Mougin and Stéphanie</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>This journal is © The Royal Society of Chemistry 2018</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Brambilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mackiewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Couvreur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem. Soc. Rev</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1147" to="1235" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">C</forename><surname>Farokhzad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Langer</surname></persName>
		</author>
		<author>
			<persName><surname>Nano</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="16" to="20" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">V</forename><surname>Delplace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Couvreur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Polym. Chem</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="1529" to="1544" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem. Mater</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1591" to="1606" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">R</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew. Chem., Int. Ed</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="4830" to="4834" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">R</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Am. Chem. Soc</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="4744" to="4754" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">R</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioconjugate Chem</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="111" to="121" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">R</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="2225" to="2232" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Q</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Baek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Dobrucki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomacromolecules</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="920" to="929" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Harrisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Maksimenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Bui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mougin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Couvreur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew. Chem., Int. Ed</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1678" to="1682" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Y</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Boissenot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Guégain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Desmaële</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Couvreur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem. Mater</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="6266" to="6275" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Y</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Guegain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mougin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Polym. Chem</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="687" to="698" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Y</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Polym. Chem</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="5174" to="5184" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Y</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Nicolas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem. Commun</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="4489" to="4492" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Bui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Maksimenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Desmaele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Harrisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vauthier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Couvreur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomacromolecules</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="2837" to="2847" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Maksimenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Bui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Desmaële</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Couvreur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem. Mater</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="3606" to="3609" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Thang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hantke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Seeberger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Tsanaktsidis and B. Lepenies</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="281" to="291" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>ChemMedChem</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">B</forename><surname>Louage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Nuhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D P</forename><surname>Risseeuw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Vanparijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Decoen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Karalic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vancalenbergh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Degeest</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angew. Chem., Int. Ed</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="11791" to="11796" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guillaneuf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lefay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bertin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gigmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Charleux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog. Polym. Sci</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="63" to="235" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">G</forename><surname>Moad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rizzardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Thang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aust. J. Chem</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="1402" to="1472" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">V</forename><surname>Delplace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Chem</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="771" to="784" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Tardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gigmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lefay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guillaneuf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem. Rev</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="1319" to="1406" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Polym. Chem</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="953" to="964" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Makromol. Chem</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="1913" to="1920" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Polym. Chem. Ed</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="3021" to="3030" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
	<note>J. Polym. Sci.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="711" to="714" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L.-L</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tetrahedron Lett</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1539" to="1540" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1574" to="1579" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">L</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Speyerer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agarwal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="7834" to="7841" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Undin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Finne-Wistrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-C</forename><surname>Albertsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomacromolecules</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="2095" to="2102" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Undin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Illanes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Finne-Wistrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-C</forename><surname>Albertsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Polym. Chem</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="1260" to="1266" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Wickel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agarwal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="6152" to="6159" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Wickel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Greiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="2397" to="2403" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Polym. Chem</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="1182" to="1188" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matyjaszewski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Polymer</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="11698" to="11706" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J.-F</forename><surname>Lutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Andrieu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Üzgün</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rudolph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agarwal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="8540" to="8543" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">C</forename><surname>Riachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schüwer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-A</forename><surname>Klok</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="8076" to="8081" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Siegwart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Bencherif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Srinivasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Hollinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matyjaszewski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biomed. Mater. Res., Part A</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="345" to="358" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J.-Y</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-Y</forename><surname>Pan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. Polym. J</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1565" to="1571" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Hedir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Ieong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Chapman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>O'reilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Dove</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="2847" to="2852" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M J</forename><surname>Paulusse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Amir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Hawker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Am. Chem. Soc</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="9805" to="9812" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Q</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matyjaszewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-L</forename><surname>Loo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="5581" to="5586" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Ganda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Eliezar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Stenzel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="4136" to="4146" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Kobben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ethirajan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Junkers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Polym. Sci., Part A: Polym. Chem</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1633" to="1641" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Hedir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>O'reilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Dove</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomacromolecules</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="2049" to="2058" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Harrisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rizzardo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="3869" to="3876" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Harrisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rizzardo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="3869" to="3876" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rizzardo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="6983" to="6989" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A.-C</forename><surname>Albertsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">K</forename><surname>Varma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomacromolecules</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="1466" to="1486" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">N</forename><surname>Grabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agarwal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromol. Chem. Phys</title>
		<imprint>
			<biblScope unit="volume">212</biblScope>
			<biblScope unit="page" from="1327" to="1334" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Q</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mitschang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agarwal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomacromolecules</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="3684" to="3691" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">T</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Polym. Chem</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="4061" to="4068" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">T</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromol. Chem. Phys</title>
		<imprint>
			<biblScope unit="volume">215</biblScope>
			<biblScope unit="page" from="1848" to="1854" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Guegain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ibrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Harrisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Polym. Chem</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="4427" to="4435" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Fessi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Puisieux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Devissaguet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ammoury</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Benita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Pharm</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="R1" to="R4" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">This journal is © The Royal Society of Chemistry</title>
		<imprint>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Chem. Sci</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="8291" to="8306" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Mura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Buchy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Askin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cayre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mougin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gouazou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sobot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Valetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Stella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Desmaele</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochimie</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="4" to="13" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Maksimenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mougin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sliwinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lepeltier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bourgaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lepêtre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zouhiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Desmaële</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Couvreur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">334</biblScope>
			<biblScope unit="page" from="346" to="353" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Hertel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Boder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Kroin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Rinzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Poore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Todd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Grindey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="4417" to="4422" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">V</forename><surname>Delplace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Guegain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Harrisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gigmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guillaneuf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem. Commun</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="12847" to="12850" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">V</forename><surname>Delplace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Harrisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gigmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guillaneuf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomacromolecules</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="2837" to="2847" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">V</forename><surname>Delplace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Harrisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gigmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guillaneuf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromol. Rapid Commun</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="484" to="491" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">V</forename><surname>Heinemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-Z</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chubb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Hertel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Grindey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Plunkett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="533" to="539" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">E</forename><surname>Guegain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Delplace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Trimaille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gigmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Siri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R A</forename><surname>Marque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guillaneuf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Polym. Chem</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="5693" to="5704" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">D</forename><surname>Gigmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H M</forename><surname>Van Steenberge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Siri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>. D'hooge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Guillaneuf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lefay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromol. Rapid Commun</title>
		<imprint>
			<biblScope unit="page">1800193</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Gooyit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Schroeder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ikejiri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Suckow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mobashery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="6676" to="6690" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">E</forename><surname>Guégain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-P</forename><surname>Michel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Boissenot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nicolas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Macromolecules</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="724" to="736" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">R</forename><surname>Ikeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Vermeulen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sachidanandam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Kolesar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int. J. Oncol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="513" to="519" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
